Monitoring of blood glucose is an invasive, painful and costly practice in diabetes. 35 Consequently, the search for a more cost-effective (reagent-free), non-invasive and 36 specific diabetes monitoring method is of great interest. Attenuated total reflectance 37 Fourier transform infrared (ATR-FTIR) spectroscopy has been used in diagnosis of 38 several diseases, however, applications in the monitoring of diabetic treatment are just 39 beginning to emerge. Here, we used ATR-FTIR spectroscopy to evaluate saliva of non-40 diabetic (ND), diabetic (D) and diabetic 6U-treated of insulin (D6U) rats to identify 41 potential salivary biomarkers related to glucose monitoring. The spectrum of saliva of 42 ND, D and D6U rats displayed several unique vibrational modes and from these, two 43 vibrational modes were pre-validated as potential diagnostic biomarkers by ROC curve 44 analysis with significant correlation with glycemia. Compared to the ND and D6U rats, 45 classification of D rats was achieved with a sensitivity of 100%, and an average specificity 46 of 93.33% and 100% using bands 1452 cm -1 and 836 cm -1 , respectively. Moreover, 1452 47 cm -1 and 836 cm -1 spectral bands proved to be robust spectral biomarkers and highly 48 correlated with glycemia (R 2 of 0.801 and 0.788, P < 0.01, respectively). Both PCA-LDA 49 and HCA classifications achieved an accuracy of 95.2%. Spectral salivary biomarkers 50 discovered using univariate and multivariate analysis may provide a novel robust 51 alternative for diabetes monitoring using a non-invasive and green technology. 52 53 54 55 56 57 58 59 60 61 62 63 64 65 67 Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia 68 which results from insufficient secretion and/or reduced insulin action in peripheral 69 tissues (Rolo e Palmeira, 2006; Ashcroft e Rorsman, 2012). According to the 70 International Diabetes Federation (IDF), there are an estimated 425 million adults with 71 diabetes worldwide, these include 212 million whom are estimated undiagnosed (IDF, 72 2017). Frequent monitoring of diabetes is essential for improved glucose control and to 73 delay clinical complications related with diabetes. Besides, the early screening of DM is 74 paramount to reduce the complications of this metabolic disorder worldwide (Uspstf, 75 2008). Despite being relatively invasive and painful, blood analysis per glucometer is 76 currently feasible for screening, monitoring and diagnosing diabetes by needle finger 77 punctures (Dowlaty et al., 2013; Mascarenhas et al., 2014). The constant need of piercing 78 the fingers several times daily by most patients is inconvenient and may lead to the 79 development of finger calluses and difficulty in obtaining blood samples (Dowlaty et al., 80 2013). 81 Saliva reflects several physiological functions of the body (Desai e Mathews, 82 2014; Javaid et al., 2016). In this way, salivary biomarkers might be an attractive 83 alternative to blood for early detection, and for monitoring systemic diseases (Hu et al., 84 2007). Among the advantages, saliva is simple to collect, non-invasive, convenient to 85 store and, compared to blood, requires less handling during clinical procedures. Besides, 86 saliva also contains analytes with real-time monitoring value which can be used to check 87 the individuals condition (Javaid et al., 2016; Zhang et al., 2016). Currently, a broad set 88 of methods are used to analyze saliva including immunoassays, colorimetric, enzymatic, 89 kinetic, chromatographic and mass spectrometric analysis (Saxena et al., 2017). Several 90 studies showed higher salivary glucose levels in DM patients than non-hyperglycemic 91 controls, which suggest that salivary glucose monitoring might be a useful in screening 92 for diabetic patients. However, other studies reject the idea of a direct relationship 93 between salivary glucose and glycemia (Mascarenhas et al., 2014; Gupta, S. et al., 2015; 94 Nunes et al., 2015; Naing e Mak, 2017). A main limitation of salivary-based measurement 95 of glucose for diabetes monitoring is the presence of glucose in foods, which can disturb 96 the monitoring process as it induces changes in salivary glucose concentration. Therefore, 97 other alternatives of salivary monitoring should be studied. 98 Infrared (IR) spectroscopy is emerging as a powerful quantitative and qualitative 99 technique for monitoring characterization of biological molecules in fluids (Bellisola e 100 Sorio, 2012). Attenuated total reflection Fourier-transform infrared (ATR-FTIR) 4 101 spectroscopy is a global, sensitive and highly reproducible physicochemical analytical 102 technique that identifies structural molecules on the basis of their IR absorption(Ojeda e 103 Dittrich , 2012). Considering that a biomolecule is determined by its unique structure, each 104 one will exhibit a unique ATR-FTIR spectrum, representing the vibrational modes of the 105 constituent structural bonds (Severcan et al., 2010; Ojeda e Dittrich, 2012). ATR-FTIR 106 is a green technology due to processes that eliminate the use of hazardous elements an 107 overarching approach that is applicable to monitoring diseases. The IR spectral modes of 108 biological samples, such as saliva, may be considered as biochemical fingerprints that 109 correlate directly with the presence or absence of diseases, and, furthermore, provide the 110 basis for the quantitative determination of several analytes for monitoring several diseases 111 and to diagnostic interest (Khaustova et al., 2010; Caetano Júnior et al., 2015). The 112 potential of salivary diagnostic for diabetes by IR spectroscopy using barium fluoride 113 (BaF 2 ) slides was suggested previously (Scott et al., 2010) , however, the efficacy of DM 114 monitoring in insulin-treated conditions using ultra-low volumes of saliva remains 115 unknown.
Introduction
completely reverted hyperglycemia and higher urine volume described in D rats. The 140 insulin treatment promoted a strong reduction in the urinary glucose concentration; 141 however, the urinary glucose concentration was increased (p < 0.05) in D6U compared 142 to ND animals.
144
Average spectra of saliva 145 A representative infrared average spectrum of saliva from normoglycemic, 146 hyperglycemic and insulin-treated conditions, which contains different molecules such as 147 lipids, proteins, glycoproteins and nucleic acid, are represented in Figure 1 . These salivary 148 spectra indicated several differences among non-diabetic, diabetic and insulin-treated 149 diabetic rats. Some bands of interest are shown in figure 1, which contains: asymmetric 150 stretching vibration of CH 2 of acyl chains of lipids (2924 cm -1 ); amide II (1549 cm -1 ); 151 asymmetric CH 3 bending modes of the methyl groups of proteins (1452 cm -1 ); amide III 152 band components of proteins (1313 cm -1 ); mannose-6-phosphate and phosphorylated 153 saccharide residue (1120 cm -1 ) and C 2 conformation of sugar (836 cm -1 ).
155
Spectral bands analyzed by IR spectroscopy 156 Spectral band areas that indicate the expression of specific molecules were 157 analyzed in saliva. The band area values of 2924 cm -1 , 1549 cm -1 , 1313 cm -1 , 1120 cm -1 158 are presented in supplementary files. Herein, we showed two bands (1452 cm -1 and 836 159 cm -1) with a higher potential for diabetes monitoring (Figure 2 and Figure 3 , bands compared with non-diabetic rats, however, insulin-treated diabetic reverted this 163 alteration in both bands ( Figure 2B and 3B, respectively) . 164 To investigate whether these salivary vibrational modes would be reflective of 165 glycemia regulation, these two salivary band areas were discovered to be, via univariate 166 analysis, the best spectral candidates values to indicate the diabetes monitoring in samples 167 with hyperglycemia, normoglycemia and under insulin treatment. Pearson's correlation 168 between these spectral modes (1452 cm -1 and 836 cm -1 ) with glycemia showed high correlation. The both salivary spectral bands presented strong negative correlation with r 170 = -0.801; p < 0.0001 for 1452 cm -1 ( Figure 2C ) and r = -0.788; p < 0.0001 for 836 cm -1 171 ( Figure 3C ).
172
Considering that sensitivity and specificity are basic characteristics to determine 173 the accuracy of diagnostic and monitoring test, ROC curve analysis were used to evaluate 174 the potential diagnostic of these spectral bands under two conditions of analysis. The first 175 one, we analyzed the condition of normoglycemic (ND and D6U) with hyperglycemic 176 (D). The cutoff value to 1452 cm -1 band was 0.405, and the corresponding sensitivity and 177 specificity were 100% and 93.3%, respectively. In ROC analysis, the area under the curve 178 (AUC) of this band was 0.988 ( Figure 2D ). To emphasizes our focus on insulin-treated 179 rats, we also showed ROC curve analysis comparing only D6U with D. Both sensitivity 180 and specificity of 1452 cm -1 band was 100% with cutoff of 0.422 (p: 0.0027). Both 181 sensitivity and specificity of 836 cm -1 band to differentiate normoglycemic (ND and 182 D6U) than hyperglycemic (D) were 100% with cutoff of 0.128 ( Figure 3D ). As expected, 183 the ROC curve to differentiate insulin-treated diabetic (D6U) than hyperglycemic (D) 184 showed similar data ( Figure 3E ). Supplementary table 1, Supplementary table 2 and Supplementary table 3 Figure 5 , as A region (2995 cm -1 to 204 2889 cm −1 ), B region (1664 cm −1 to 1581 cm −1 ), C region ( 1410 cm −1 to 1234 cm −1 ), D 205 region (1149 cm −1 the 1080 cm −1 ) and E region (1018 cm −1 to 955 cm −1 ) which allowed 206 the differentiation of the non-diabetic, diabetic and insulin-treated diabetic. As seen from 207 the figure 5, all non-diabetics and diabetics were separate with 100% of discrimination.
208
Only one insulin-treated diabetic was categorized as non-diabetic. The total accuracy, 209 which is highly important for potential monitoring applications, was 95.2% (20/21). The development of a novel, rapid, noninvasive tool for the diagnosis, and the 214 most important, for monitoring diabetes mellitus based on the comprehensive analysis of 215 spectral salivary constituents would be of great use to health clinical. Herein, we have 216 investigated the translational applicability of ATR-FTIR spectroscopy with potential 217 monitoring of metabolic control in diabetes. Six potential spectral bands were detected 218 by ATR-FTIR and, from these, two bands were showed a strong correlation with glycemia 219 and high sensibility and specificity to differentiate hyperglycemic than normoglycemic 220 conditions indicating potential monitoring applicability for diabetes. The discriminatory 221 power of these two salivary ATR-FTIR bands area are candidates for monitoring diabetes 222 under insulin therapy.
223
As expected in diabetic state, plasma glucose, urine volume and urine glucose 224 concentration are increased in non-treated diabetic rats compared to non-diabetic rats. In 
243
The spectral analysis method to dried saliva described in the present study may be These two salivary spectral modes showed a high and significant correlation with 261 the metabolic control. Clinically, the most interesting comparisons are the correlation 262 between these salivary spectral band areas and glycemia. Together, these salivary spectral 263 bands showed a 100% of sensitivity and 100% of specificity in ROC analysis. ROC curve 264 analysis is widely considered to be the most objective and statistically valid method for 265 biomarker performance evaluation (Xia et al., 2013) . Regarding the potential for 266 translation to the clinic, our results suggest that two salivary band areas, 1452 cm -1 and 267 836 cm -1 can be considered a non-invasive spectral biomarkers of monitoring diabetes 268 treated with insulin. Different drug treatments and several levels of glucose concentration 269 should ideally be possible to differentiate, therefore more studies need be investigated. 270 These results indicate that these spectral modes can be used as a diagnostic and 9 271 monitoring platform for diabetes mellitus, once interestingly, insulin treatment was also 272 able to revert the salivary spectra observed in hyperglycemic state. Therefore, insulin 273 treatment is not a potential confounding factor that may influence salivary vibrational 
293
Cluster analyses confirm its potential to discriminate ND, D and D6U groups with 294 high accuracy. The success rate for ND e D was 100 %, and for D6U was 85.7%. 
314
In conclusion, we showed that ATR-FTIR spectroscopy in saliva is able to 315 differentiate diabetic from non-diabetic and insulin-treated diabetic rats. Our data suggest 316 specific fingerprint regions (highlighted two salivary spectral modes 1452 cm -1 and 836 317 cm -1 ) capable of discriminating between hyperglycemic and normoglycemic conditions 318 (insulin treated or not) in univariate analysis. A very high discriminatory accuracy of 319 95.2% was also obtained for classifying infrared spectra of saliva between diabetic, non-320 diabetic and insulin-treated rats by the PCA-LDA and HCA multivariate models. In 321 summary, these salivary results indicate that ATR-FTIR spectroscopy coupled with 322 univariate or multivariate chemometric analysis has the potential to provide a novel non-323 invasive approach to diabetes monitoring assisting medical decision making to avoid 324 under-treatment or over-treatment with insulin. 
Chemical profile in stimulated saliva by ATR-FTIR Spectroscopy
Salivary spectra were recorded in 3000 cm -1 to 400 cm -1 region using ATR-FTIR 373 spectrophotometer Vertex 70 (Bruker Optics, Reinstetten, Germany) using a micro-374 attenuated total reflectance (ATR) component. The crystal material in ATR unit was a 375 diamond disc as internal-reflection element. The salivary pellicle penetration depth 376 ranges between 0.1 and 2 μm and depends on the wavelength, incidence angle of the beam 377 and the refractive index of ATR-crystal material. In the ATR-crystal the infrared beam is 378 reflected at the interface toward the sample. Saliva was directly dried using airflow on 379 ATR-crystal for 2 min before salivary spectra recorded. The air spectra was used as a 380 background in ATR-FTIR analysis. Sample spectra and background was taken with 4 cm -381 1 of resolution and 32 scans were performed for salivary analysis.
383
Spectra data evaluation procedures 384 The spectra data obtained were processed using Opus 6.5 software (Bruker Optics, 385 Reinstetten, Germany). Measurements were performed in mid-infrared region (3000-400 386 cm -1 ) with spectral resolution of 4 cm -1 and 32 scans per spectrum. Samples were pressed 387 into ATR diamond crystal with standardized pressure. For the generation of mean spectra 388 and band areas, the spectra were normalized by vector and baseline corrected to avoid 389 errors during the sample preparations and spectra analysis. To evaluate the mean values The quantity 1-specificity is the false positive rate and is the percentage of rats that are 400 incorrectly identified as diabetic (D).
401
The sensitivity or true positive rate is defined as the percentage of rats who are correctly followed by linear discriminant analysis (PCA-LDA) and 409 Hierarchical Cluster Analysis (HCA) 410 The principal components were calculated using a full range of the FT-IR spectra 411 (ND, D and DU6) between 3700 and 500 cm-1, and a covariance matrix. The first step 412 was normalization followed by mean centering, the data were analyzed using the principal 413 components analysis (PCA). In this study, the first six principal components (PC1-PC6) 414 were used to perform the linear discriminant analysis (LDA) with leave-one-out cross-415 validation, according to the pathological reports.
416
Infrared spectra of saliva samples were also analyzed by OPUS software (version 
